Your browser doesn't support javascript.
loading
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Gupta, Vikas; Malone, Adriana K; Hari, Parameswaran N; Ahn, Kwang Woo; Hu, Zhen-Huan; Gale, Robert Peter; Ballen, Karen K; Hamadani, Mehdi; Olavarria, Eduardo; Gerds, Aaron T; Waller, Edmund K; Costa, Luciano J; Antin, Joseph H; Kamble, Rammurti T; van Besien, Koen M; Savani, Bipin N; Schouten, Harry C; Szer, Jeffrey; Cahn, Jean-Yves; de Lima, Marcos J; Wirk, Baldeep; Aljurf, Mahmoud D; Popat, Uday; Bejanyan, Nelli; Litzow, Mark R; Norkin, Maxim; Lewis, Ian D; Hale, Gregory A; Woolfrey, Ann E; Miller, Alan M; Ustun, Celalettin; Jagasia, Madan H; Lill, Michael; Maziarz, Richard T; Cortes, Jorge; Kalaycio, Matt E; Saber, Wael.
Afiliación
  • Gupta V; Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: vikas.gupta@uhn.on.ca.
  • Malone AK; Mount Sinai Medical Center, New York, New York.
  • Hari PN; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Ahn KW; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hu ZH; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Gale RP; Section of Hematology, Division of Experimental Medicine, Department of Medicine, Imperial College, London, UK.
  • Ballen KK; Massachusetts General Hospital, Boston, Massachusetts.
  • Hamadani M; West Virginia University Hospitals, Morgantown, West Virginia.
  • Olavarria E; Hematology Department and BMT Unit, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Gerds AT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Waller EK; Bone Marrow and Stem Cell Transplant Center, Emory University Hospital, Atlanta, Georgia.
  • Costa LJ; Blood and Marrow Transplant Program, Medical University of South Carolina, Charleston, South Carolina.
  • Antin JH; Dana Farber Cancer Institute, Boston, Massachusetts.
  • Kamble RT; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • van Besien KM; Stem Cell Transplant Program, Weill Cornell Medical College, New York, New York.
  • Savani BN; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schouten HC; Academische Ziekenhuis Maastricht, Maastricht, The Netherlands.
  • Szer J; Clinical Haematology and BMT Service, Royal Melbourne Hospital, Victoria, Australia.
  • Cahn JY; Department of Hematology, University Hospital, Grenoble, France.
  • de Lima MJ; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
  • Wirk B; Department of Hematology/Oncology, Shands HealthCare and University of Florida, Gainesville, Florida.
  • Aljurf MD; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Popat U; Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, Houston, Texas.
  • Bejanyan N; Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Litzow MR; Mayo Clinic Rochester, Rochester, Minnesota.
  • Norkin M; Department of Hematology/Oncology, Shands HealthCare and University of Florida, Gainesville, Florida.
  • Lewis ID; Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital/SA Pathology, Adelaide, Australia.
  • Hale GA; All Children's Hospital, St Petersburg, Florida.
  • Woolfrey AE; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Miller AM; Baylor University Medical Center, Dallas, Texas.
  • Ustun C; Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Jagasia MH; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lill M; Division of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
  • Maziarz RT; Center for Hematologic Malignancies, Oregon Health and Science University, Portland, Oregon.
  • Cortes J; Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, Houston, Texas.
  • Kalaycio ME; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Saber W; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.
Biol Blood Marrow Transplant ; 20(1): 89-97, 2014 Jan.
Article en En | MEDLINE | ID: mdl-24161923
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Agonistas Mieloablativos / Mielofibrosis Primaria Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Agonistas Mieloablativos / Mielofibrosis Primaria Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos